| Literature DB >> 31027998 |
Lisa Schmidleithner1, Yasser Thabet2, Eva Schönfeld2, Maren Köhne1, Daniel Sommer2, Zeinab Abdullah3, Timothy Sadlon4, Collins Osei-Sarpong1, Kotha Subbaramaiah5, Francesca Copperi6, Kristian Haendler7, Tamas Varga8, Oliver Schanz9, Svenja Bourry8, Kevin Bassler2, Wolfgang Krebs2, Annika E Peters10, Ann-Kathrin Baumgart10, Maria Schneeweiss2, Kathrin Klee2, Susanne V Schmidt2, Simone Nüssing2, Jil Sander2, Naganari Ohkura11, Andreas Waha12, Tim Sparwasser13, F Thomas Wunderlich14, Irmgard Förster9, Thomas Ulas2, Heike Weighardt9, Shimon Sakaguchi11, Alexander Pfeifer6, Matthias Blüher15, Andrew J Dannenberg5, Nerea Ferreirós16, Louis J Muglia17, Claudia Wickenhauser18, Simon C Barry4, Joachim L Schultze7, Marc Beyer19.
Abstract
Regulatory T cells (Treg cells) are important for preventing autoimmunity and maintaining tissue homeostasis, but whether Treg cells can adopt tissue- or immune-context-specific suppressive mechanisms is unclear. Here, we found that the enzyme hydroxyprostaglandin dehydrogenase (HPGD), which catabolizes prostaglandin E2 (PGE2) into the metabolite 15-keto PGE2, was highly expressed in Treg cells, particularly those in visceral adipose tissue (VAT). Nuclear receptor peroxisome proliferator-activated receptor-γ (PPARγ)-induced HPGD expression in VAT Treg cells, and consequential Treg-cell-mediated generation of 15-keto PGE2 suppressed conventional T cell activation and proliferation. Conditional deletion of Hpgd in mouse Treg cells resulted in the accumulation of functionally impaired Treg cells specifically in VAT, causing local inflammation and systemic insulin resistance. Consistent with this mechanism, humans with type 2 diabetes showed decreased HPGD expression in Treg cells. These data indicate that HPGD-mediated suppression is a tissue- and context-dependent suppressive mechanism used by Treg cells to maintain adipose tissue homeostasis.Entities:
Keywords: Foxp3; HPGD; PGE(2); adipose tissue; regulatory T cells; suppressive function; type 2 diabetes
Mesh:
Substances:
Year: 2019 PMID: 31027998 DOI: 10.1016/j.immuni.2019.03.014
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745